The Dow Jones closed higher on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Gainers Biocept, Inc. (NASDAQ: BIOC) shares jumped 97.6% to $1.6608 after the company announced non-exclusive licensing agreement for CNSide with Plus Therapeutics.
NeuBase Therapeutics (NASDAQ: NBSE) saw significant interest and gained a whopping 106% after the company announced a 20% acquisition of their shares by Symetryx Corporation. To add to the excitement, Symetryx is now urging Neubase's Board of Directors to consider issuing a special dividend of $1 per share to the company's shareholders. Symetryx has acquired
U.S. stocks traded mostly lower this morning, with the Nasdaq Composite falling more than 200 points on Thursday. Following the market opening Thursday, the Dow traded up 0.02% to 34,449.20 while the NASDAQ fell 1.57% to 13,655.13. The S&P 500, also fell, dropping, 0.72% to 4,433.23.